These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21161440)

  • 1. Preoperative serum thyroid stimulating hormone levels in well-differentiated thyroid carcinoma is a predictive factor for lateral lymph node metastasis as well as extrathyroidal extension in Korean patients: a single-center experience.
    Kim SS; Lee BJ; Lee JC; Song SH; Kim BH; Son SM; Kim IJ; Kim YK; Kang YH
    Endocrine; 2011 Jun; 39(3):259-65. PubMed ID: 21161440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
    Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
    J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.
    Choi JS; Kim EK; Moon HJ; Kwak JY
    Endocrine; 2015 Feb; 48(1):264-71. PubMed ID: 24858734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hashimoto's thyroiditis, microcalcification and raised thyrotropin levels within normal range are associated with thyroid cancer.
    Ye ZQ; Gu DN; Hu HY; Zhou YL; Hu XQ; Zhang XH
    World J Surg Oncol; 2013 Mar; 11():56. PubMed ID: 23496874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
    Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension.
    Haymart MR; Glinberg SL; Liu J; Sippel RS; Jaume JC; Chen H
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):434-9. PubMed ID: 19067720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
    Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
    Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern analysis for prognosis of differentiated thyroid cancer according to preoperative serum thyrotropin levels.
    Kim H; Jung J; Cho YS; Choi JY; Park H; Lee YB; Kim SW; Chung JH; Kim TH
    Sci Rep; 2021 Nov; 11(1):22322. PubMed ID: 34785735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
    McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
    Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Clinicopathological Factors of the Tumor with Preoperative TSH Level in Papillary Thyroid Cancers.
    Besler E; Citgez B; Aygun N; Celayir MF; Ozguven MBY; Mihmanli M; Yetkin SG; Uludag M
    Eurasian J Med; 2019 Feb; 51(1):8-11. PubMed ID: 30911248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
    Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer.
    Aydoğan Bİ; Mutlu ABB; Yüksel S; Güllü S; Emral R; Demir Ö; Şahin M; Gedik VT; Çorapçıoğlu D; Sak SD; Erdoğan MF
    Endocr Pathol; 2021 Jun; 32(2):280-287. PubMed ID: 33188468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors and Outcomes of Postoperative Recurrent Well-Differentiated Thyroid Cancer: A Single Institution's 15-Year Experience.
    Amin SN; Shinn JR; Naguib MM; Netterville JL; Rohde SL
    Otolaryngol Head Neck Surg; 2020 Apr; 162(4):469-475. PubMed ID: 32069184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer.
    Bortz MD; Kuchta K; Winchester DJ; Prinz RA; Moo-Young TA
    Surgery; 2021 Jan; 169(1):2-6. PubMed ID: 32682508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography.
    Lee CY; Kim SJ; Ko KR; Chung KW; Lee JH
    J Ultrasound Med; 2014 Feb; 33(2):231-8. PubMed ID: 24449725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of coexistent Hashimoto's thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma.
    Qu N; Zhang L; Lin DZ; Ji QH; Zhu YX; Wang Y
    Tumour Biol; 2016 Jun; 37(6):7685-92. PubMed ID: 26692097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension.
    Zhang X; Zhang L; Xue S; Wang P; Chen G
    Asian J Surg; 2019 Apr; 42(4):563-570. PubMed ID: 30078501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer.
    Zeng RC; Jin LP; Chen ED; Dong SY; Cai YF; Huang GL; Li Q; Jin C; Zhang XH; Wang OC
    Head Neck; 2016 Apr; 38 Suppl 1():E1019-25. PubMed ID: 26041461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.